Robot takes the joystick for brain surgery – first human test underway
NCT ID NCT06752096
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early study is testing whether a robot can help doctors perform delicate brain blood vessel procedures, such as angiography, embolization, and thrombectomy. Ten patients scheduled for these standard procedures will have them done using a robotic system instead. The main goal is to see if the robot can successfully navigate to the target blood vessel.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Vasco Robotic system
- What this could lead to
- If successful, this could show that robot-assisted brain procedures are safe and effective, paving the way for larger studies and potentially more precise treatments.
- What could go wrong
- This is a very small, early exploratory study with only 10 participants. It is not designed to prove the robot is better than standard care, and technical failures or complications are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients scheduled for neurovascular interventions, such as diagnostic cerebral angiography for cerebrovascular diseases, arterial embolization for meningioma treatment, and thrombectomy for thrombotic arterial occlusion-induced cerebral ischemia, are selected according to the same criteria as standard cerebral angiography and interventional procedures. Exclusion Criteria: Exclusion Criteria 1 (General): 1. Patients who have undergone surgery within 4 weeks prior to study participation or have not fully recovered from surgery. 2. Patients who are pregnant or breastfeeding. 3. Patients with existing or anticipated vasospasm, bleeding, or severe atheromatous disease. 4. Patients allergic to contrast agents used in angiography. 5. Patients with renal failure. 6. Patients with a history of cardiac events, such as myocardial infarction or superior vena cava (SVC) syndrome, within 3 months prior to study participation, or with existing heart disease. 7. Patients unable to cooperate due to difficulty in expressing intent to the extent that the procedure cannot proceed. 8. Patients with severe or life-threatening comorbidities that could significantly affect symptom improvement or render the procedure unbeneficial. 9. Patients with non-life-threatening comorbidities that prevent proper follow-up for treatment. Exclusion Criteria 2 (Cerebral Ischemic Stroke Patient): 1. Patients with an ASPECTS score of 0-2 on a pre-treatment non-contrast CT. 2. Inability to perform femoral puncture within 60 minutes of completing CT angiography (if CT perfusion is performed, it must be done after CT angiography). 3. Absence of a femoral pulse. 4. Cases where vascular access is highly challenging, with an anticipated time exceeding 90 minutes from CT angiography to reperfusion. 5. Patients suspected to have cerebral artery dissection or atherosclerosis as the cause of stroke. 6. Patients where the intracranial occlusion is determined to be chronic based on clinical history, prior imaging, or clinical judgment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cerebrovascular disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Severence Hospital, Yonsei University College of Medicine
RECRUITINGSeoul, Korea, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Zapping the spine while wearing a robotic ankle: a new way to help kids walk?
- Can a nurse and a neighbor help tame chronic disease?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Two ways to catch a hidden heart rhythm after stroke